137 related articles for article (PubMed ID: 3838352)
1. [Inhibition of platelet aggregation and thromboxane formation by the calcium antagonist nisoldipine following a single oral dose of 10 mg. A double-blind study in healthy probands].
Schrör K; Latta G; Darius H; Klaus W; Ziegler R
Klin Wochenschr; 1985 Jan; 63(1):16-9. PubMed ID: 3838352
[TBL] [Abstract][Full Text] [Related]
2. Effects of nisoldipine on cytosolic calcium, platelet aggregation, and coagulation/fibrinolysis in patients with coronary artery disease.
Fujinishi A; Takahara K; Ohba C; Nakashima Y; Kuroiwa A
Angiology; 1997 Jun; 48(6):515-21. PubMed ID: 9194537
[TBL] [Abstract][Full Text] [Related]
3. In vitro effects of two novel calcium antagonists (nitrendipine and nisoldipine) on intraplatelet calcium redistribution, platelet aggregation and thromboxane A2 formation. Comparison with diltiazem, nifedipine and verapamil.
Rostagno C; Abbate R; Gensini GF; Coppo M; Prisco D; Boddi M; Neri Serneri GG
Thromb Res; 1991 Aug; 63(4):457-62. PubMed ID: 1754998
[No Abstract] [Full Text] [Related]
4. The effect of nisoldipine on whole blood platelet aggregation in patients with Raynaud's phenomenon.
Francis JL; Roath OS; Challenor VF; Waller DG
Br J Clin Pharmacol; 1988 Jun; 25(6):751-4. PubMed ID: 3203045
[TBL] [Abstract][Full Text] [Related]
5. Effects of verapamil and nisoldipine on human platelets: in vivo and in vitro studies.
Jones CR; Pasanisi F; Elliott HL; Reid JL
Br J Clin Pharmacol; 1985 Sep; 20(3):191-6. PubMed ID: 2994701
[TBL] [Abstract][Full Text] [Related]
6. Effects of calcium channel blockers on platelet aggregation and thromboxane A2 formation: an in vivo double blind randomized study.
Rostagno C; Prisco D; Paniccia R; Costanzo G; Poggesi L; Boddi M; Abbate R
Thromb Res; 1990 Aug; 59(3):531-9. PubMed ID: 2237825
[TBL] [Abstract][Full Text] [Related]
7. Ex vivo platelet studies following oral nisoldipine in normotensive insulin-dependent diabetics and non-diabetic controls.
Hendra TJ; Oughton J; Jeremy JY; Smith CC; Betteridge DJ; Dandona P; Yudkin JS
Diabetes Res; 1988 Jul; 8(3):117-22. PubMed ID: 2976336
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics and hemodynamic effects of nisoldipine and its interaction with cimetidine.
van Harten J; van Brummelen P; Lodewijks MT; Danhof M; Breimer DD
Clin Pharmacol Ther; 1988 Mar; 43(3):332-41. PubMed ID: 3345623
[TBL] [Abstract][Full Text] [Related]
9. Effects of the calcium antagonist nifedipine on thromboxane B2 level and platelet aggregation in hypertensive patients.
Uehara S; Handa H; Hirayama A
Arzneimittelforschung; 1986 Nov; 36(11):1687-9. PubMed ID: 3814228
[TBL] [Abstract][Full Text] [Related]
10. Inhibitory effect of a selective thromboxane A2 receptor antagonist, EP 092, on platelet aggregation in whole blood ex vivo and in vivo.
Booth RF; Honey AC; Lad N; Tuffin DP; Wade PJ
Br J Pharmacol; 1989 Feb; 96(2):395-405. PubMed ID: 2522336
[TBL] [Abstract][Full Text] [Related]
11. A comparison of the haemodynamic effects of nifedipine, nisoldipine and nitrendipine in man.
Debbas NM; Jackson SH; Turner P
Eur J Clin Pharmacol; 1986; 30(4):393-7. PubMed ID: 2943594
[TBL] [Abstract][Full Text] [Related]
12. Effects of fenflumizole on aggregation ex vivo of human platelets and formation of thromboxane B2 and 6-keto-prostaglandin-F1 alpha.
Vinge E; Corell T; Andersson KE
Eur J Clin Pharmacol; 1984; 26(6):711-7. PubMed ID: 6436029
[TBL] [Abstract][Full Text] [Related]
13. Studies on the effect of two angiotensin-converting enzyme inhibitors, captopril and cilazapril, on platelet and vascular prostaglandin metabolism in vivo.
Wagner B; Eichler HG; Schneider B; Blöchl-Daum B; Brenner B; Gasic S; Lechner K; Kyrle PA
Naunyn Schmiedebergs Arch Pharmacol; 1992 Oct; 346(4):453-6. PubMed ID: 1436129
[TBL] [Abstract][Full Text] [Related]
14. The pharmacodynamics and pharmacokinetics of a new calcium antagonist nisoldipine in normotensive and hypertensive subjects.
Pasanisi F; Meredith PA; Reid JL
Eur J Clin Pharmacol; 1985; 29(1):21-4. PubMed ID: 4054203
[TBL] [Abstract][Full Text] [Related]
15. Influence of renal function on the pharmacokinetics and cardiovascular effects of nisoldipine after single and multiple dosing.
van Harten J; Burggraaf J; van Brummelen P; Breimer DD
Clin Pharmacokinet; 1989 Jan; 16(1):55-64. PubMed ID: 2706880
[TBL] [Abstract][Full Text] [Related]
16. [Comparison of the anti-ischemia effect of nisoldipine and verapamil. Double-blind randomized cross-over and placebo-controlled acute and long-term study].
Brügmann U; Blasini R; Rudolph W
Herz; 1984 Aug; 9(4):244-52. PubMed ID: 6434387
[TBL] [Abstract][Full Text] [Related]
17. [Antiaggregant effect and tolerance of calcium carbasalate administrated immediately after aorto-coronary bypass. Results of a double-blind versus placebo study].
Mathieu P; Villemot JP; Stoltz JF; Scheck F; Garnier LF
Pathol Biol (Paris); 1996 Jun; 44(6):571-80. PubMed ID: 8977914
[TBL] [Abstract][Full Text] [Related]
18. Nisoldipine: kinetics and effects on blood pressure and heart rate in patients with liver cirrhosis after intravenous and oral administration.
van Harten J; van Brummelen P; Wilson JH; Lodewijks MT; Breimer DD
Eur J Clin Pharmacol; 1988; 34(4):387-94. PubMed ID: 3402524
[TBL] [Abstract][Full Text] [Related]
19. Effects of repeated oral doses of fenflumizole on platelet aggregation and thromboxane formation in man ex vivo.
Dahl-Puustinen ML; Corell T; Koch K; Puustinen T
Prostaglandins Leukot Essent Fatty Acids; 1988 Feb; 31(2):101-6. PubMed ID: 3357910
[TBL] [Abstract][Full Text] [Related]
20. Effects of verapamil and nisoldipine on human platelets: in vivo and in vitro studies.
Jeremy JY; Barradas MA; Mikhailidis DP; Dandona P
Br J Clin Pharmacol; 1986 Aug; 22(2):201-2. PubMed ID: 3756069
[No Abstract] [Full Text] [Related]
[Next] [New Search]
